Human type IIIL-1β decoy receptor:: Potential for gene therapy in arthritis

被引：0
|
作者：
Amin, AR
Attur, MG
Dave, MN
Cipolletta, C
Woo, SLC
Meseck, M
Abramson, SB
机构：
[1] Hosp Joint Dis & Med Ctr, New York, NY 10003 USA
[2] CUNY Mt Sinai Sch Med, New York, NY 10029 USA
来源：
FASEB JOURNAL | 2001年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A695 / A695
页数：1
相关论文
共 50 条
  • [31] Identification of cis-elements of the human endothelin-A receptor gene and inhibition of the gene expression by the decoy strategy
    Yamashita, J
    Yoshimasa, T
    Arai, H
    Hiraoka, J
    Takaya, K
    Miyamoto, Y
    Ogawa, Y
    Itoh, H
    Nakao, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (26) : 15993 - 15999
  • [32] Activation of transient receptor potential vanilloid receptor type 1 inhibits human monocyte migration
    Liu, D. Y.
    Ma, L. Q.
    Luo, Z. D.
    Cao, T. B.
    Wang, L. J.
    Tepel, Martin
    Zhu, Z. M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E64 - E64
  • [33] Gene transfer to human joints: Progress toward a gene therapy of arthritis
    Evans, CH
    Robbins, PD
    Ghivizzani, SC
    Wasko, MC
    Tomaino, MM
    Kang, R
    Muzzonigro, TA
    Vogt, M
    Elder, EM
    Whiteside, TL
    Watkins, SC
    Herndon, JH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (24) : 8698 - 8703
  • [34] Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding
    Cui, XL
    Rouhani, FN
    Hawari, F
    Levine, SJ
    JOURNAL OF IMMUNOLOGY, 2003, 171 (12): : 6814 - 6819
  • [35] THE TYPE-II DECOY RECEPTOR - A NOVEL REGULATORY PATHWAY FOR INTERLEUKIN-1
    COLOTTA, F
    DOWER, SK
    SIMS, JE
    MANTOVANI, A
    IMMUNOLOGY TODAY, 1994, 15 (12): : 562 - 566
  • [36] Allelic variants of the angiotensin type 1 receptor gene and human heart size
    Chiu, I.
    Di Nicolantonio, R.
    Ellis, J. A.
    Cobb, J. E.
    Scurrah, K. J.
    Zaloumis, S. G.
    Harrap, S. B.
    Jennings, G. L. R.
    Reid, C. M.
    Wing, L.
    HYPERTENSION, 2007, 49 (06) : 1467 - 1467
  • [37] Permanent prevention of hypertension by angiotensin type 1 receptor antisense gene therapy in the SHR
    Reaves, PY
    Wang, HW
    Yang, H
    Katovich, MJ
    Berecek, K
    Raizada, MK
    FASEB JOURNAL, 1999, 13 (05): : A776 - A776
  • [38] Gene Therapy in Type 1 Diabetes
    Bagley, Jessamyn
    Paez-Cortez, Jesus
    Tian, Chaorui
    Iacomini, John
    CRITICAL REVIEWS IN IMMUNOLOGY, 2008, 28 (04) : 301 - 324
  • [39] Gene therapy for type 1 diabetes
    Ayuso, E.
    Mann, C.
    Anguela, X.
    Bosch, F.
    AVANCES EN DIABETOLOGIA, 2010, 26 (01): : 6 - 12
  • [40] Gene therapy for Type 1 diabetes
    Fenjves, ES
    Ricordi, C
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (03) : 325 - 331
12345